Literature DB >> 21276335

NICE guidelines for chronic obstructive pulmonary disease: implications for primary care.

Kevin Gruffydd-Jones, Melvyn M Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21276335      PMCID： PMC3026147          DOI： 10.3399/bjgp11X556182

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  6 in total

1.  COPD guidelines: the important thing is not to stop questioning.

Authors:  Leonardo M Fabbri; Piera Boschetto; Cristina E Mapp
Journal:  Am J Respir Crit Care Med       Date:  2007-09-15       Impact factor: 21.405

2.  Diagnostic spirometry in primary care: Proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations: a General Practice Airways Group (GPIAG)1 document, in association with the Association for Respiratory Technology & Physiology (ARTP)2 and Education for Health3 1 www.gpiag.org 2 www.artp.org 3 www.educationforhealth.org.uk.

Authors:  Mark L Levy; Philip H Quanjer; Rachel Booker; Brendan G Cooper; Steve Holmes; Iain Small
Journal:  Prim Care Respir J       Date:  2009-09

3.  The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.

Authors:  Bartolome R Celli; Claudia G Cote; Jose M Marin; Ciro Casanova; Maria Montes de Oca; Reina A Mendez; Victor Pinto Plata; Howard J Cabral
Journal:  N Engl J Med       Date:  2004-03-04       Impact factor: 91.245

4.  Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index.

Authors:  Rupert C Jones; Gavin C Donaldson; Niels H Chavannes; Kozui Kida; Maria Dickson-Spillmann; Samantha Harding; Jadwiga A Wedzicha; David Price; Michael E Hyland
Journal:  Am J Respir Crit Care Med       Date:  2009-09-24       Impact factor: 21.405

5.  Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care.

Authors: 
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

6.  Development and first validation of the COPD Assessment Test.

Authors:  P W Jones; G Harding; P Berry; I Wiklund; W-H Chen; N Kline Leidy
Journal:  Eur Respir J       Date:  2009-09       Impact factor: 16.671
  6 in total
  5 in total

1.  Limitations of End-Tidal CO2 Measured with a Portable Capnometer to Estimate PaCO2 for Patients with Respiratory Disease.

Authors:  Takatoshi Enomoto; Yoshikazu Inoue; Yuichi Adachi; Shunichi Kouno; Yuji Inagaki; Koji Azuma; Kanako Katayama; Naoko Takeuchi; Yoshinobu Matsuda
Journal:  Turk Thorac J       Date:  2021-05

2.  The use of COPD maintenance therapy following spirometry in General Practice.

Authors:  Vibeke Gottlieb; Anne Marie Lyngsø; Ditte Sæbye; Anne Frølich; Vibeke Backer
Journal:  Eur Clin Respir J       Date:  2016-06-22

3.  When rheumatologists report that they agree with a guideline, does this mean that they practise the guideline in clinical practice? Results of the International Recommendation Implementation Study (IRIS).

Authors:  Emilia Gvozdenović; Cornelia F Allaart; Désirée van der Heijde; Gianfranco Ferraccioli; Josef S Smolen; Tom W J Huizinga; Robert Landewé
Journal:  RMD Open       Date:  2016-04-28

4.  Pulmonary function parameters among marble industry workers in Lahore, Pakistan.

Authors:  Imran Maqsood Butt; Tajammal Mustafa; Shahnaz Rauf; Anjum Razzaq; Javaria Anwer
Journal:  F1000Res       Date:  2021-09-17

5.  Cost versus utility of aclidinium bromide 400 µg plus formoterol fumarate dihydrate 12 µg compared to aclidinium bromide 400 µg alone in the management of moderate-to-severe COPD.

Authors:  Mafalda Ramos; John Haughney; Nathaniel Henry; Leandro Lindner; Mark Lamotte
Journal:  Clinicoecon Outcomes Res       Date:  2016-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.